PR95692

PALO ALTO, Calif., April 28, 2022 /PRNewswire=KYODO JBN/ --

Glooko, Inc., a leading provider of remote patient monitoring and data

management solutions for diabetes and related chronic conditions, today

announced the appointment of Alfonso "Chito" Zulueta to its Board of Directors.

Logo - https://mma.prnewswire.com/media/1043398/Glooko_Logo.jpg

Respected as a leader with a strong track record of success in the

pharmaceutical industry and deep experience on corporate boards and industry

associations, Mr. Zulueta comes to the Glooko Board having served as a senior

executive leading a wide range of global business and commercial units over his

more than 30-year career with Eli Lilly and Company. The Glooko leadership team

and Board welcome the breadth and depth of experience he brings as the company

continues its strategic growth as a digital health leader in chronic disease

management.

"We are very excited for Chito to join our Board and particularly fortunate for

his strong understanding of the impact that digital health solutions can have

on managing chronic diseases," said Russ Johannesson, CEO of Glooko. "He brings

a wealth of valuable experience and unique perspectives to our Board, having

led successful global healthcare ventures focused on treating diabetes and

other diseases. Chito's appointment comes at a critical time for Glooko, as we

continue to broaden our digital therapeutics (DTx) and clinical research

businesses."

Mr. Zulueta retired at the end of 2021 from his roles at Lilly as an executive

committee member, corporate officer and president of the company's

international business unit, where  he was responsible for leading Lilly's

business in all geographies outside of the U.S. and Canada. Prior to that, he

served as Lilly's president of its Emerging Market business unit, president of

Japan, president of Global Oncology and Critical Care product group, vice

president in charge of U.S. sales and marketing for the neuroscience and

diabetes/family health business unit, and vice president of global marketing.

"This is a compelling time to join the Glooko Board as the Company expands its

offerings and commercial footprint," said Mr. Zulueta. "Glooko is rapidly

increasing its market relevance and is driving real innovation through its

digital health solutions, serving more patients and healthcare professionals

globally. I'm excited to leverage my experience and insights to help Glooko

accelerate this growth and evolution."

Mr. Zulueta also serves on the boards of directors of CTS Corporate, Syneos

Health, and Calidi Biotherapeutics, Inc. He served previously on the boards of

industry associations, including the European Federation of Pharmaceutical

Industries and Associations (chairman of the international committee), PhRMA

(chairman of the Japan business executive committee), the American Chamber of

Commerce of Japan (governor of the Kansai chapter), and the U.S.- Japan

Business Council.

Mr. Zulueta earned an MBA from the Darden School of Business Administration of

the University of Virginia and a bachelor's degree in economics from De La

Salle University.

About Glooko

Glooko is transforming digital health by connecting people with diabetes and

related chronic conditions with their healthcare teams, enabling collaborative

telehealth, clinical research and improved health outcomes. The company's

software platforms collect and analyze data from multiple devices in one highly

secure place, allowing for easy remote upload via app or in-clinic, and

producing easy-to-read analytics through actionable charts and graphs. The

platform is compatible with over 95% of global diabetes and health monitoring

devices, giving patients and their providers flexibility in how to manage their

conditions. With over 35 billion data points, Glooko is the global leader in

diabetes patient data. Glooko's solutions can be found in 31 countries across

22 languages. Learn more at www.glooko.com .

Media Inquiries:

Tanya Rodante

Director of Global Communication, Glooko

tanya.rodante@glooko.com

+1 415-608-5295

SOURCE: Glooko